Tango Therapeutics (TNGX) Other Operating Expenses (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Other Operating Expenses of -$36.8 million for Q1 2026, up 5.9% year-over-year from -$34.7 million in Q1 2025, and up 5.9% quarter-over-quarter from -$39.1 million in Q1 2025.
Tango Therapeutics (TNGX) Other Operating Expenses (2020 - 2026) Analysis & Trends
Tango Therapeutics' Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$36.8 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.79 Mn |
| Mar 31, 2025 | -39.10 Mn |
| Dec 31, 2024 | 122.03 Mn |
| Sep 30, 2024 | -36.97 Mn |
| Dec 31, 2020 | 2.91 Mn |